Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro

Journal of Nutrition

Volumn 139, Issue 8, 2009, Pages 1603-1608

  Zunino, Susan J ^a   Storms, David H ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD19 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KAEMPFEROL; POKEWEED MITOGEN; PROTEIN BCL 2; QUERCETIN; RESVERATROL;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; ANTIGENS, CD19; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; B-LYMPHOCYTES; CASPASE 3; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; GENES, BCL-2; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KAEMPFEROLS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PLANT EXTRACTS; POKEWEED MITOGENS; QUERCETIN; STILBENES; YOUNG ADULT;

PHYTOLACCACEAE;

EID: 67749114244     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.105064     Document Type: Article

References (30)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24:2783-840.
2. Bravo L. Polyphenols: chemistry, dietary sources, metabolism and nutritional significance. Nutr Rev. 1998;56:317-33.
3. Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets. 2007;6:168-73.
4. Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL, Etherton TD. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr. 2004;24:511-38.
5. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY, Jeong WI, Ryu SY, Do SH, et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem. 2003;243:153-60.
6. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007;2007:45673.
7. O'Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O'Brien NM, Williamson G. Effect of flavanoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res. 2004;551:245-54.
8. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature. 1994;367:425-8.
9. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331-60.
10. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu D-H, Kastelein R, Moore KW, Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA. 1992;89:1890-3.
11. Wyllie AH. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-305.
12. Fischer U, Jänicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003;10:76-100.
13. Chao DT, Korsemeyer SJ. Bcl-2 family: regulators of cell death. Annu Rev Immunol. 1998;16:395-419.
14. Droin NM, Green DR. Role of Bcl-2 family members in immunity and disease. Biochim Biophys Acta. 2004;1644:179-88.
15. Sharma S, Chopra K, Kulkarni SK, Agrewala JN. Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin Exp Immunol. 2007;147:155-63.
16. Keightley RG, Cooper MD, Lawton AR. The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol. 1976;117: 1538-44.
17. Jelinek DF, Lipsky PE. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man. J Immunol. 1983;130:2597-604.
18. O'Reilly LA, Harris AW, Tarlington DM, Corcoran LM, Strasser A. Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J Immunol. 1997;159:2301-11.
19. Grumont RJ, Rourke IJ, O'Reilly LA, Strasser A, Miyake K, Sha W, Gerondakis S. B lymphcytes differentially use the Rel and Nuclear Factor kB1 (NF-kB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med. 1998;187:663-74.
20. Greider C, Chattopadhyay A, Parkhurst C, Yang E. Bcl-xL and Bcl2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Oncogene. 2002;21:7765-75.
21. Kip1, pRB relative p130, and altered E2F regulation. Mol Cell Biol. 2000;20: 4745-53.
22. Huang DCS, O'Reilly LA, Strasser A, Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 1997;16:4628-38.
23. Tarlinton D. Germinal centers: form and function. Curr Opin Immunol. 1998;10:245-51.
24. Smith KGC, Light A, O'Reilly L, Ang S-M, Strasser A, Tarlington D. bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody forming cells. J Exp Med. 2000;191:475-84.
25. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32:1377-82.
26. Boocock DJ, Faust GES, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowll JA, Perloff M, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16:1246-52.
27. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: extent of absorption, glucoronidation, and enterhepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther. 2002;302:369-73.
28. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Merillon J-M. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003;72:2219-33.
29. Abd El-Mohsen M, Bayele H, Kuhnle G, Gibson G, Debnam E, Kaila Srai S, Rice-Evans C, Spencer JPE. Distribution of [3H]trans-resveratrol in rat tissues following oral administration. Br J Nutr. 2006;96:62-70.
30. Wenzel E, Soldo T, Erbersdobler H, Somoza V. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res. 2005;49:482-94.